Sort By:

Oral COVID Vaccine

This is a clinical research study to evaluate the effectiveness of an oral COVID vaccine in healthy adults, when compared to currently available COVID vaccines. Participants must have had at least two COVID vaccines greater than 6 months ago.

You can contact our office at 501-500-4270 or fill out the short "Do You Qualify" Questionnaire to see if you qualify for this study. Please click "View Trial Details"

View Trial Details
Ages 18+
Compensation* $900+ for study related time and travel
Study Topics Oral COVID Vaccine for Healthy Adults

*Compensation for time and travel may be available to those who qualify.

RSV in Adults who have had Solid Organ Transplants (Lung or Liver)

This is a Phase 3 study to evaluate the safety and effectiveness of an mRNA vaccine targeting Respiratory Syncytial Virus (RSV) in:

- Those that have had a Solid Organ Transplant (Lung or Liver).

RSV (Respiratory Syncytial Virus) is a common cause of severe respiratory disease in immunocompromised adults, and in solid organ transplant recipients. RSV is associated with significant morbidity and mortality.

You can contact our office at 501-500-4270 or fill out the short "Do You Qualify" Questionnaire to see if you qualify for this study.

View Trial Details
Ages 18+
Compensation* Up to $3,000 for study related time and travel
Study Topics Evaluating a vaccine for RSV in Adults who have had Solid Organ transplants

*Compensation for time and travel may be available to those who qualify.